Back to Search
Start Over
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Alvotech for Development & Commercialization of a Proposed Biosimilar to Xolair[R] (omalizumab)
- Source :
- Business Wire. October 3, 2023
- Publication Year :
- 2023
-
Abstract
- PISCATAWAY, N.J. & REYKJAVIK, Iceland -- Kashiv Biosciences LLC ('Kashiv'), a fully integrated biopharmaceutical company, and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.767546709